Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathy

Movement Disorders

Volumn 14, Issue 5, 1999, Pages 855-859

  Chariot, Patrick ^a   Brugières, Pierre ^a   Eliezer Vanerot, Marie Christine ^b   Gény, Christian ^a   Binaghi, Michel ^a   Césaro, Pierre ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Chorea; Coenzyme Q10; Leber hereditary optic neuropathy; Mitochondria; MRI; Optic neuropathy

Indexed keywords

LACTIC ACID; PYRUVIC ACID; UBIDECARENONE; VITAMIN;

ADULT; ARTICLE; CASE REPORT; CENTRAL SCOTOMA; CHOREA; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FAMILY HISTORY; GENE MUTATION; HEREDITARY OPTIC ATROPHY; HUMAN; LACTATE BLOOD LEVEL; MALE; MOTOR DYSFUNCTION; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC DISK; OPTIC NERVE ATROPHY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; VISUAL FIELD; VISUAL IMPAIRMENT;

ADULT; ANTIOXIDANTS; CHOREATIC DISORDERS; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OPTIC ATROPHIES, HEREDITARY; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; UBIQUINONE; VITAMINS;

EID: 0032752681     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(199909)14:5<855::AID-MDS1023>3.0.CO;2-9     Document Type: Article

References (35)

1. Harding AE, Sweeney MG. Leber's hereditary optic neuropathy. In: Di Mauro S, Schapira AHV, eds. Mitochondrial Disorders in Neurology. Oxford: Butterworth-Heinemann, 1994:181-198.
2. Howell N, Halvorson S, Burns J, McCullough DA, Poulton J. When does bilateral optic atrophy become Leber hereditary optic neuropathy? Am J Hum Genet 1993;53:959-963.
3. Mackey DA, Oostra RJ, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 1996;59:481-485.
4. Schapira AHV. Evidence for mitochondrial dysfunction in Parkinson's disease: a critical reappraisal. Mov Disord 1994;9:125-138.
5. Shoffner J, Brown MD, Stugard C, et al. Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation. Ann Neurol 1995;38:163-169.
6. De Vries DD, Went LN, Bruyn GW, et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 1996;58:703-711.
7. Schapira AHV. Inborn and induced defects of mitochondria. Arch Neurol 1998;55:1293-1296.
8. Chariot P, Ratiney R, Ammi-Saïd M, Herigault R, Adnot S, Gherardi R. Optimal handling of blood samples for routine measurement of lactate and pyruvate. Arch Pathol Lab Med 1994;118:695-697.
9. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-983.
10. Johns DR, Heher KL, Miller NR, Smith KH. Leber's hereditary optic neuropathy; clinical manifestations of the 14 484 mutation. Arch Ophthalmol 1993;111:495-498.
11. Salmaggi A, Carrara F, Zeviani M. Remarkable recovery of visual function in a patient with Leber's optic neuropathy and multiple mutations of mitochondrial DNA. Int J Neurosci 1994;77:261-266.
12. Riordan-Eva P, Sanders MD, Govan GG, et al. The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain 1995; 118:319-337.
13. Johns DR, Berman J. Alternative, simultaneous complex I mitochondrial DNA mutations in Leber's hereditary optic neuropathy. Biochem Biophys Res Commun 1991;174:1324-1330.
14. Howell N, Kubacka I, Xu M, McCullough DA. Leber hereditary optic neuropathy: involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. Am J Hum Genet 1991;48:935-942.
15. Uziel G, Moroni I, Lamantea E, et al. Mitochondrial disease associated with the T8993G mutation of the mitochondrial ATPase 6 gene: a clinical, biochemical, and molecular study in six families. J Neurol Neurosurg Psychiatry 1997;63:16-22.
16. Mariotti C, Uziel G, Carrara F, et al. Early-onset encephalopathy associated with tissue specific mitochondrial DNA depletion: a morphological, biochemical and molecular-genetic study. J Neurol 1995;242:547-556.
17. Larsson NG, Andersen O, Holme E, Oldfors A, Wahlström J. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol 1991;30:701-708.
18. Chan C, Mackey DA, Byrne E. Sporadic Leber hereditary optic neuropathy in Australia and New Zealand. Aust NZ J Ophthalmol 1996;24:7-14.
19. Kermode AG, Moseley IF, Kendall BE, Miller DH. Magnetic resonance imaging in Leber's optic neuropathy. J Neurol Neurosurg Psychiatry 1989;52:671-674.
20. Dotti MT, Caputo N, Signorini E, Federico A. Magnetic resonance imaging findings in Leber's hereditary optic neuropathy. Eur Neurol 1992;32:17-19.
21. Harding AE, Sweeney MG, Miller DH, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992;115:979-989.
22. Nikoskelainen EK, Marttila RJ, Huoponen K, Juvonen V. Leber's 'plus': neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995;59: 160-164.
23. Osborn AG. Inherited metabolic, white matter, and degenerative diseases of the brain. In: Osborn AG, ed. Diagnostic Neuroradiolagy. Chicago, IL: Mosby Yearbook, 1994:716-747.
24. Simmons JT, Pastakia B, Chase TN, Shults CW. Magnetic resonance imaging in Huntington disease. AJNR Am J Neuroradiol 1986;7:25-28.
25. Konagaya M, Konagaya Y. MRI in hemiballism due to Sydenham's chorea. J Neurol Neurosurg Psychiatry 1992;55:238-239.
26. Emery ES, Vieco PT. Sydenham chorea: magnetic resonance imaging reveals permanent basal ganglia injury. Neurology 1997;48: 531-533.
27. Lee MS, Marsden CD. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord 1994;9:493-507.
28. Higgins JJ, Patterson MC, Papadopoulos NM, et al. Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP syndrome). Neurology 1992;42:194-198.
29. Sunden-Cullberg J, Tedroff J, Aquilonius SM. Reversible chorea in primary antiphospholipid syndrome. Mov Disord 1998;13:147-149.
30. Lockshin MD. Antiphospholipid antibody. Babies, blood clots, biology. JAMA 1997;277:1549-1551.
31. Ogasahara S, Nishikawa Y, Yorifuji S, et al. Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology 1986;36:45-53.
32. Matthews PM, Ford B, Dandurand RJ, et al. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 1993;43:884-890.
33. Mashima Y, Hiida Y, Oguchi Y. Remission of Leber's hereditary optic neuropathy with idebenone. Lancet 1992;340:368-369.
34. Cortelli P, Montagna P, Pierangeli G, et al. Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study. J Neurol Sci 1997;148:25-31.
35. Mackey D, Howell N. A variant of Leber hereditary optic neuropathy characterized by recovery of vision and by unusual mitochondrial genetic etiology. Am J Hum Genet 1992;51:1218-1228.